Side-by-side comparison
GHK-Cu vs BPC-157
Built from the published sections of each compound page. Empty cells mean that part hasn’t been published yet, not that there’s nothing to know.
Informational only. This doesn’t rank the two, recommend either, or suggest using them together.
Regulatory status
- GHK-Cu
- Research only (US)
- BPC-157
- Research only (US)
Class
- GHK-Cu
- Naturally occurring copper-binding tripeptide (Glycyl-L-Histidyl-L-Lysine + Cu²⁺)
- BPC-157
- Synthetic 15-amino-acid peptide (pentadecapeptide) from human gastric juice
Half-life
- GHK-Cu
- Plasma <1 hour; tissue effects last days
- BPC-157
- ~30 minutes (parenteral)
Evidence
- GHK-Cu
- Not published yet
- BPC-157
- Not published yet
How it works
- GHK-Cu
- Not published yet
- BPC-157
- Not published yet
Research evidence
- GHK-Cu
- Not published yet
- BPC-157
- Not published yet
Side effects
- GHK-Cu
- Not published yet
- BPC-157
- Not published yet
Contraindications
- GHK-Cu
- Not published yet
- BPC-157
- Not published yet
Monitoring markers
- GHK-Cu
- Not published yet
- BPC-157
- Complete Blood Count (CBC), Comprehensive Metabolic Panel (CMP), Fasting Blood Glucose, High-Sensitivity C-Reactive Protein (hs-CRP), IGF-1 (Insulin-like Growth Factor 1)
Main uncertainties
- GHK-Cu
- Still in editorial review: quick overview, what it is, what researchers are studying, how it works.
- BPC-157
- Still in editorial review: quick overview, what it is, what researchers are studying, how it works.
Expert disagreements
- GHK-Cu
- Not published yet
- BPC-157
- Not published yet
Questions?
Send me a message and I’ll point you to the right guide or source.